{"id":51913,"date":"2019-08-25T10:25:27","date_gmt":"2019-08-25T08:25:27","guid":{"rendered":"https:\/\/cms.munich-startup.net\/?p=51913"},"modified":"2019-08-23T10:37:26","modified_gmt":"2019-08-23T08:37:26","slug":"million-dollar-investment-for-the-molecular-diagnostics-startup-gna-biosolutions","status":"publish","type":"post","link":"https:\/\/cms.munich-startup.net\/en\/51913\/million-dollar-investment-for-the-molecular-diagnostics-startup-gna-biosolutions\/","title":{"rendered":"Molecular diagnostics startup GNA Biosolutions closes Series C financing round"},"content":{"rendered":"
\n

The molecular diagnostics startup<\/a> GNA Biosolutions has closed a $13.5 million Series C financing round, attracting new investors including Greybird Ventures, Occident, and Wachstumsfonds Bayern.<\/strong><\/p>\n\n\n\n

But also well-known financiers<\/a> such as SHS Gesellschaft f\u00fcr Beteiligungsmanagement, Robert Bosch Venture Capital, UVC Partners<\/a>, Mey Capital Matrix, KfW and Btov Partners are back on board. <\/p>\n\n\n\n

"Rapid molecular diagnostics are key to patient care in an increasingly broad range of therapeutic areas, particularly in infectious diseases. We believe that PCA technology will overcome many limitations of existing molecular diagnostics and enable rapid treatment decisions that improve patient care." <\/p><\/blockquote>\n\n\n\n

says Tom Miller<\/strong>, Partner at Greybird Ventures, the lead investor in the financing round.<\/p>\n\n\n\n

These are the next steps<\/h2>\n\n\n\n

The new investment is planned by the molecular diagnostics startup GNA Biosolutions for the further development of PCA technology (Pulsed Control Amplification)<\/a> The technology can amplify nucleic acids directly from samples such as whole blood, sputum, and nasal swabs. The company also aims to obtain CE-IVD marking for its point-of-care molecular diagnostics platform. To achieve this, in vitro diagnostics (IVDs) must comply with certain guidelines. GNA Biosolutions plans to launch the platform first in Europe and later in the US. It has already been used in several tests to detect infectious diseases and biothreats.<\/p>\n\n\n\n

\u201cThis Series C financing will help us implement our regulatory strategy and bring PCA into the clinic,\u201d <\/p><\/blockquote>\n\n\n\n

commented Federico Buersgens<\/strong>, Co-founder and Managing Director of GNA Biosolutions.<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"

The molecular diagnostics startup GNA Biosolutions has closed a $13.5 million Series C financing round. The company attracted new investors such as Greybird Ventures, Occident, and Wachstumsfonds Bayern. It also attracted established investors such as SHS Gesellschaft f\u00fcr Beteiligungsmanagement, Robert Bosch Venture Capital, UVC Partners, Mey Capital Matrix, KfW, and Btov Partners.<\/p>","protected":false},"author":32,"featured_media":51951,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[5633,1],"tags":[52,3276],"acf":[],"yoast_head":"\nMolekulardiagnostik-Startup GNA Biosolutions schlie\u00dft Serie-C Finanzierungsrunde ab - Munich Startup<\/title>\n<meta name=\"description\" content=\"GNA Biosolutions, das M\u00fcnchner Molekulardiagnostik-Startup hat eine Serie-C-Finanzierungsrunde mit 13,5 USD abgeschlossen.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cms.munich-startup.net\/en\/51913\/million-dollar-investment-for-the-molecular-diagnostics-startup-gna-biosolutions\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Molekulardiagnostik-Startup GNA Biosolutions schlie\u00dft Serie-C Finanzierungsrunde ab - Munich Startup\" \/>\n<meta property=\"og:description\" content=\"GNA Biosolutions, das M\u00fcnchner Molekulardiagnostik-Startup hat eine Serie-C-Finanzierungsrunde mit 13,5 USD abgeschlossen.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cms.munich-startup.net\/en\/51913\/million-dollar-investment-for-the-molecular-diagnostics-startup-gna-biosolutions\/\" \/>\n<meta property=\"og:site_name\" content=\"Munich Startup\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/munichstartup\/\" \/>\n<meta property=\"article:published_time\" content=\"2019-08-25T08:25:27+00:00\" \/>\n<meta name=\"author\" content=\"Sandra Ohse\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@munich_startup\" \/>\n<meta name=\"twitter:site\" content=\"@munich_startup\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Sandra Ohse\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cms.munich-startup.net\/51913\/millioneninvestment-fuer-das-molekulardiagnostik-startup-gna-biosolutions\/\",\"url\":\"https:\/\/cms.munich-startup.net\/51913\/millioneninvestment-fuer-das-molekulardiagnostik-startup-gna-biosolutions\/\",\"name\":\"Molekulardiagnostik-Startup GNA Biosolutions schlie\u00dft Serie-C Finanzierungsrunde ab - Munich Startup\",\"isPartOf\":{\"@id\":\"https:\/\/cms.munich-startup.net\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cms.munich-startup.net\/51913\/millioneninvestment-fuer-das-molekulardiagnostik-startup-gna-biosolutions\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cms.munich-startup.net\/51913\/millioneninvestment-fuer-das-molekulardiagnostik-startup-gna-biosolutions\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2019\/08\/laboratory-2815632_1920.jpg\",\"datePublished\":\"2019-08-25T08:25:27+00:00\",\"author\":{\"@id\":\"https:\/\/cms.munich-startup.net\/#\/schema\/person\/44fefd0f3018683bdae7561770a1aba7\"},\"description\":\"GNA Biosolutions, das M\u00fcnchner Molekulardiagnostik-Startup hat eine Serie-C-Finanzierungsrunde mit 13,5 USD abgeschlossen.\",\"breadcrumb\":{\"@id\":\"https:\/\/cms.munich-startup.net\/51913\/millioneninvestment-fuer-das-molekulardiagnostik-startup-gna-biosolutions\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cms.munich-startup.net\/51913\/millioneninvestment-fuer-das-molekulardiagnostik-startup-gna-biosolutions\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cms.munich-startup.net\/51913\/millioneninvestment-fuer-das-molekulardiagnostik-startup-gna-biosolutions\/#primaryimage\",\"url\":\"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2019\/08\/laboratory-2815632_1920.jpg\",\"contentUrl\":\"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2019\/08\/laboratory-2815632_1920.jpg\",\"width\":1920,\"height\":1316,\"caption\":\"GNA Biosolutions\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cms.munich-startup.net\/51913\/millioneninvestment-fuer-das-molekulardiagnostik-startup-gna-biosolutions\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cms.munich-startup.net\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Molekulardiagnostik-Startup GNA Biosolutions schlie\u00dft Serie-C Finanzierungsrunde ab\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cms.munich-startup.net\/#website\",\"url\":\"https:\/\/cms.munich-startup.net\/\",\"name\":\"Munich Startup\",\"description\":\"Das offizielle Startup-Portal f\u00fcr M\u00fcnchen\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cms.munich-startup.net\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/cms.munich-startup.net\/#\/schema\/person\/44fefd0f3018683bdae7561770a1aba7\",\"name\":\"Sandra Ohse\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cms.munich-startup.net\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/2992d97bee6e35981a21dc63e5da9a89?s=96&d=blank&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/2992d97bee6e35981a21dc63e5da9a89?s=96&d=blank&r=g\",\"caption\":\"Sandra Ohse\"},\"description\":\"Sandra Ohse hat bisher als Redakteurin f\u00fcr eine bekannte Computer-Zeitschrift \u00fcber die neuesten technischen Innovationen berichtet. Nun freut sie sich darauf, in die Welt der Startups einzutauchen, kreative K\u00f6pfe kennenzulernen und sie auf ihrem Weg redaktionell zu begleiten.\",\"url\":\"https:\/\/cms.munich-startup.net\/en\/author\/sandra\/\"}]}<\/script>\n<meta property=\"og:image\" content=\"https:\/\/cms.munich-startup.net\/en\/wp-content\/uploads\/2019\/08\/laboratory-2815632_1920.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1920\" \/>\n\t<meta property=\"og:image:height\" content=\"1316\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Molecular diagnostics startup GNA Biosolutions closes Series C financing round - Munich Startup","description":"GNA Biosolutions, the Munich-based molecular diagnostics startup, has closed a Series C financing round with USD 13.5 million.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cms.munich-startup.net\/en\/51913\/million-dollar-investment-for-the-molecular-diagnostics-startup-gna-biosolutions\/","og_locale":"en_US","og_type":"article","og_title":"Molekulardiagnostik-Startup GNA Biosolutions schlie\u00dft Serie-C Finanzierungsrunde ab - Munich Startup","og_description":"GNA Biosolutions, das M\u00fcnchner Molekulardiagnostik-Startup hat eine Serie-C-Finanzierungsrunde mit 13,5 USD abgeschlossen.","og_url":"https:\/\/cms.munich-startup.net\/en\/51913\/million-dollar-investment-for-the-molecular-diagnostics-startup-gna-biosolutions\/","og_site_name":"Munich Startup","article_publisher":"https:\/\/www.facebook.com\/munichstartup\/","article_published_time":"2019-08-25T08:25:27+00:00","author":"Sandra Ohse","twitter_card":"summary_large_image","twitter_creator":"@munich_startup","twitter_site":"@munich_startup","twitter_misc":{"Written by":"Sandra Ohse","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/cms.munich-startup.net\/51913\/millioneninvestment-fuer-das-molekulardiagnostik-startup-gna-biosolutions\/","url":"https:\/\/cms.munich-startup.net\/51913\/millioneninvestment-fuer-das-molekulardiagnostik-startup-gna-biosolutions\/","name":"Molecular diagnostics startup GNA Biosolutions closes Series C financing round - Munich Startup","isPartOf":{"@id":"https:\/\/cms.munich-startup.net\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cms.munich-startup.net\/51913\/millioneninvestment-fuer-das-molekulardiagnostik-startup-gna-biosolutions\/#primaryimage"},"image":{"@id":"https:\/\/cms.munich-startup.net\/51913\/millioneninvestment-fuer-das-molekulardiagnostik-startup-gna-biosolutions\/#primaryimage"},"thumbnailUrl":"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2019\/08\/laboratory-2815632_1920.jpg","datePublished":"2019-08-25T08:25:27+00:00","author":{"@id":"https:\/\/cms.munich-startup.net\/#\/schema\/person\/44fefd0f3018683bdae7561770a1aba7"},"description":"GNA Biosolutions, the Munich-based molecular diagnostics startup, has closed a Series C financing round with USD 13.5 million.","breadcrumb":{"@id":"https:\/\/cms.munich-startup.net\/51913\/millioneninvestment-fuer-das-molekulardiagnostik-startup-gna-biosolutions\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cms.munich-startup.net\/51913\/millioneninvestment-fuer-das-molekulardiagnostik-startup-gna-biosolutions\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cms.munich-startup.net\/51913\/millioneninvestment-fuer-das-molekulardiagnostik-startup-gna-biosolutions\/#primaryimage","url":"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2019\/08\/laboratory-2815632_1920.jpg","contentUrl":"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2019\/08\/laboratory-2815632_1920.jpg","width":1920,"height":1316,"caption":"GNA Biosolutions"},{"@type":"BreadcrumbList","@id":"https:\/\/cms.munich-startup.net\/51913\/millioneninvestment-fuer-das-molekulardiagnostik-startup-gna-biosolutions\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cms.munich-startup.net\/"},{"@type":"ListItem","position":2,"name":"Molekulardiagnostik-Startup GNA Biosolutions schlie\u00dft Serie-C Finanzierungsrunde ab"}]},{"@type":"WebSite","@id":"https:\/\/cms.munich-startup.net\/#website","url":"https:\/\/cms.munich-startup.net\/","name":"Munich Startup","description":"The official startup portal for Munich","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cms.munich-startup.net\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/cms.munich-startup.net\/#\/schema\/person\/44fefd0f3018683bdae7561770a1aba7","name":"Sandra Ohse","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cms.munich-startup.net\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/2992d97bee6e35981a21dc63e5da9a89?s=96&d=blank&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/2992d97bee6e35981a21dc63e5da9a89?s=96&d=blank&r=g","caption":"Sandra Ohse"},"description":"Sandra Ohse previously reported on the latest technological innovations as an editor for a well-known computer magazine. She's now looking forward to diving into the world of startups, meeting creative minds, and accompanying them on their journey editorially.","url":"https:\/\/cms.munich-startup.net\/en\/author\/sandra\/"}]},"og_image":[{"width":1920,"height":1316,"url":"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2019\/08\/laboratory-2815632_1920.jpg","type":"image\/jpeg"}]},"_showyear":"","_inactive":"","_show_financing":"","_hide_on_map":"","_edit_lock":"1641217476:38","_edit_last":"22","_yoast_wpseo_focuskw":"Molekulardiagnostik-Startup GNA Biosolutions","_yoast_wpseo_metadesc":"GNA Biosolutions, das M\u00fcnchner Molekulardiagnostik-Startup hat eine Serie-C-Finanzierungsrunde mit 13,5 USD abgeschlossen.","_yoast_wpseo_linkdex":"71","_thumbnail_id":"51951","wbounce_status":"default","_yoast_wpseo_primary_category":"5633","_yoast_wpseo_focuskw_text_input":"","_yoast_wpseo_content_score":"90","ms_image_format":"contentwidth","_ms_image_format":"field_5cb8587572c8b","ms_dachzeile":"","_ms_dachzeile":"field_5cd9b7f365df5","ms_bump_post_date":"","_ms_bump_post_date":"field_5d1341edcf42a","guest_author_name":"","_guest_author_name":"field_5cee78a6016f9","guest_author_image":"","_guest_author_image":"field_5cee7914016fb","guest_author_description":"","_guest_author_description":"field_5cee78dd016fa","ms_post_image_caption":"","_ms_post_image_caption":"","ms_post_image_credit":"","_ms_post_image_credit":"","suppress_startupbox":"","_suppress_startupbox":"","_yoast_wpseo_estimated-reading-time-minutes":"","_wp_old_date":"","_yoast_wpseo_title":"","_yoast_wpseo_wordproof_timestamp":"","footnotes":"","easy_language_simplification_original_id":"","easy_language_source_language":"","easy_language_simplification_language":"","easy_language_api":"","easy_language_prevent_automatic_mode":"","_wp_old_slug":"","_wp_trash_meta_status":"","_wp_trash_meta_time":"","easy_language_simplification_state_changed_from":"","easy_language_de_EL_changed":"","ms_competition_deadline":"","_ms_competition_deadline":"","_wpbitly":"","enclosure":"","_yoast_wpseo_meta-robots-noindex":"","_yoast_wpseo_meta-robots-nofollow":"","wbounce_template":"","wbounce_title":"","wbounce_text":"","wbounce_cta":"","wbounce_url":"","wbounce_override":"","_yoast_wpseo_opengraph-title":"","_yoast_wpseo_opengraph-description":"","_oembed_7131efca3705e16bd9da2c41df237660":"","_oembed_time_7131efca3705e16bd9da2c41df237660":"","_pprredirect_type":"","_pprredirect_url":"","_yoast_wpseo_opengraph-image":"","_yoast_wpseo_opengraph-image-id":"","_newsletterglue":"","easy_language_text_language":"","_wp_desired_post_slug":"","_relevanssi_noindex_reason":"","_links":{"self":[{"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/posts\/51913"}],"collection":[{"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/users\/32"}],"replies":[{"embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/comments?post=51913"}],"version-history":[{"count":5,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/posts\/51913\/revisions"}],"predecessor-version":[{"id":52022,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/posts\/51913\/revisions\/52022"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/media\/51951"}],"wp:attachment":[{"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/media?parent=51913"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/categories?post=51913"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/tags?post=51913"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}